Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-35 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
filingDate |
2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89dfd1e1e98d3de5d9ace2385b496b06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaaa024eec59427699acaa88023d52fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d02c9990cf09ee7e1451aee144a2dff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73a8d4cc16357235942e34e3fda3ffb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ceba070752048340ff9a5b6d9aadd3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f49797ce74d2791464ff3695ec2f42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa94e4debd1ff1fff49b15bbdfffa5ce |
publicationDate |
2016-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2015206890-A1 |
titleOfInvention |
Long-acting insulin and use thereof |
abstract |
The present invention relates to: an insulin analog in which the insulin receptor binding force is reduced for the purpose of increasing the half-life of insulin in the blood; a long-acting insulin using the same; a complex; and a method for preparing the long-acting insulin. |
priorityDate |
2014-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |